SC 13G Filing

Company

TENAX THERAPEUTICS, INC.

Filed

March 28, 2014

Accession Number

0000930413-14-001498

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →